pentazocine
Vérifier sur tripsit
Pentazocine
Vérifier sur isomerdesign
Pentazocine
Vérifier sur pubchem
Pentazocine
Vérifier sur drugmap
Pentazocine
Vérifier sur drugmap
Pentazocine
Vérifier sur wiki
Data
InChI: InChI=1S/C19H27NO/c1-13(2)7-9-20-10-8-19(4)14(3)18(20)11-15-5-6-16(21)12-17(15)19/h5-7,12,14,18,21H,8-11H2,1-4H3
Synonymes: NIH 7958, Fortal (TN),Pentagin,Pentazocine [USAN:USP:INN:BAN:JAN],RP4A60D26L,2-(3,3-Dimethylallyl)-2',2'-hydroxy-5,9-dimethyl-6,7-benzomorphan,Pentazocinum, Fortral,Pentazocine civ, (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol,CHEMBL560,WIN-20228,Fortral (TN),(2R,6R,11R)-6,11-dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol,(+)-[3H]-Pentazocine, Pentazocine (JP15/USP/INN),Sosigon,Pentazocine,359-83-1,UNII-RP4A60D26L,PENTAZOCINE [EP MONOGRAPH], Talwin NX (TN),KF-1820,(+)-Pentazocine,D00498,Pentazocine 2R,6R,11R-form,WIN 20,228, Pentagin, 2-Dimethylallyl-5,9-dimethyl-2'-hydroxybenzomorphan,(+-)-Pentazocine,cis-(+-)-Pentazocine,Pentazocine, L-,2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-,PENTAZOCINE [MART.], KF-1820, Pentazocaine,Pentazocine,(+/-),Pentazocine, (-)-,cis-(-)-Pentazocine,359-83-1 (free base),Fortalgesic,UNII-768DQ5A5AI,DB00652,SCHEMBL2492,Pentazocine 2R,6R,11R-form [MI],2-(3,3-Dimethylallyl)cyclazocine,2,6-METHANO-3-BENZAZOCIN-8-OL, 1,2,3,4,5,6-HEXAHYDRO-6,11-DIMETHYL-3-(3-METHYL-2-BUTENYL)-, (2R,6R,11R)-,dl-Pentazocine, (2alpha,6alpha,11R*)-(1)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzazocin-8-ol,2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2alpha,6alpha,11R*)-,PENTAZOCINE [USAN],768DQ5A5AI,II-C-2, Fortalin,Q415793,3-(3-Methyl-2-butenyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol,EINECS 206-634-6, Talwin PX (TN),(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol,7488-49-5, Fortral (TN), Pentazocine [USAN:INN:BAN:JAN], Pentazocinum [INN-Latin], L-pentazocine,DTXSID7023433,Fortalin, Talwin (TN), 3-(3-Methyl-2-butenyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol,PENTAZOCINE [INN], Pentazocinum,(-)-alpha-Pentazocine,2,6-METHANO-3-BENZAZOCIN-8-OL, 1,2,3,4,5,6-HEXAHYDRO-6,11-DIMETHYL-3-(3-METHYL-2-BUTENYL)-, CIS-(-)-,PENTAZOCINE [MI],talwin, WIN 20228,PENTAZOCINE [HSDB],PENTAZOCINE (+),GTPL1606,(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.0?,?]trideca-2,4,6-trien-4-ol,(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.0^{2,7}]trideca-2,4,6-trien-4-ol,(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.0?,?]trideca-2(7),3,5-trien-4-ol,ZINC596,PENTAZOCINE [EP IMPURITY],(+/-)-pentazocine,HSDB 3150, Pentazocina, Talacen,6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol(Pentazocine),rel-(2R,6R,11R)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol, 2-(3,3-Dimethylallyl)-2',2'-hydroxy-5,9-dimethyl-6,7-benzomorphan, Soseton,Pentazocaine,Pentazocina [DCIT],(2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol,2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-, (2R,6R,11R)-rel-,Levopentazocine,PENTAZOCINE (-), (2R,6R,11R)-6,11-dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol,Pentazocin,Pentazocinum [INN-Latin],Pentazocina, Talwan,(2R,6R,11R)-6,11-dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methanobenzo[d]azocin-8-ol,PENTAZOCINE [JAN],(2R,6R,11R)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol,NSC 107430, CHEMBL2311194,cis-(+/-)-Pentazocine, 1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzazocin-8-ol,(2R,6R,11R)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-2,6-methano-3-benzazocin-8-ol, Pentazocine, Pentazocin, Sosegon, WIN 20228,Sosegon,(-)-PENTAZOCINE,WIN 20228,(2alpha,6alpha,11R*)-(1)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzazocin-8-ol, 2-(3,3-Dimethylallyl)cyclazocine, Algopent (free base),Pentazocine (JP17/USP/INN),C07421, Sosigon, 1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol,(6R,11S)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol,2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-, (2R,6R,11R)-,(-)-.ALPHA.-PENTAZOCINE,L-pentazocine,CHEBI:7982,FT-0673607,2'-Hydroxy-5,9-dimethyl-2-(3,3-dimethylallyl)-6,7-benzomorphan,2-Dimethylallyl-5,9-dimethyl-2'-hydroxybenzomorphan, Pentazocin,pentazocine, Talacen (TN), II-C-2, 2'-Hydroxy-5,9-dimethyl-2-(3,3-dimethylallyl)-6,7-benzomorphan,NIH-7958, NIH 7958,PENTAZOCINE [WHO-DD],PENTAZOCINE [USP MONOGRAPH],[3H]pentazocine,EINECS 244-593-6, Liticon, [3H]pentazocine, Sosegon,PENTAZOCINE CIV [USP-RS], Lexir, Fortwin (TN), Pentazocina [DCIT],6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol,BDBM50001028, [3H]-(+)-Pentazocine,PENTAZOCINE [VANDF]
Estimated data
Solubility: -3.656 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)
Addictivity Prediction: 98.0% (prediction based on www.mdpi.com)
